Search Results - "Aber, Florence"

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF) by Nabisere, Ruth, Musaazi, Joseph, Denti, Paolo, Aber, Florence, Lamorde, Mohammed, Dooley, Kelly E, Aarnoutse, Rob, Sloan, Derek J, Sekaggya-Wiltshire, Christine

“…Tuberculosis (TB) is a significant public health problem that causes substantial morbidity and mortality. Current first-line anti-TB chemotherapy, although…”
Get full text

“It is not easy”: Experiences of people living with HIV and tuberculosis on Tuberculosis treatment in Uganda by Nabisere-Arinaitwe, Ruth, Namatende-Sakwa, Lydia, Bayiga, Josephine, Nampala, Juliet, Alinaitwe, Lucy, Aber, Florence, Otaalo, Brian, Musaazi, Joseph, King, Rachel, Kesby, Mike, Sloan, Derek J., Sekaggya-Wiltshire, Christine

“…Completion of tuberculosis (TB) treatment presents several challenges to patients, including long treatment duration, medication adverse-effects and heavy pill…”
Get full text

Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin by Sekaggya-Wiltshire, Christine, Nabisere, Ruth, Musaazi, Joseph, Otaalo, Brian, Aber, Florence, Alinaitwe, Lucy, Nampala, Juliet, Najjemba, Letisha, Buzibye, Allan, Omali, Denis, Gausi, Kamunkhwala, Kengo, Allan, Lamorde, Mohammed, Aarnoutse, Rob, Denti, Paolo, Dooley, Kelly E, Sloan, Derek J

“…Higher doses of rifampicin may improve treatment outcomes and reduce the duration of tuberculosis (TB) therapy. However, drug-drug interactions with…”
Get full text